Table 5. Univariate analysis and multivariate analysis of the correlation of the expression of riskScore with OS among glioma patients.
| Gene | coef | HR | HR.95L | HR.95H | pvalue |
|---|---|---|---|---|---|
| ASB4 | -1.915 | 1.473 | 0.022 | 0.972 | 0.047 |
| CCIN | 2.358 | 10.575 | 0.930 | 120.310 | 0.057 |
| CDRT1 | -1.376 | 0.253 | 0.045 | 1.408 | 0.116 |
| DCAF4L2 | -2.074 | 0.126 | 0.028 | 0.570 | 0.007 |
| DTL | -5.875 | 0.003 | 0.000 | 0.050 | 6.58E-05 |
| RNF148 | -2.301 | 0.100 | 0.006 | 1.603 | 0.104 |
| TRIM31 | 2.062 | 7.862 | 0.655 | 94.415 | 0.104 |
| TRIM54 | -2.249 | 0.106 | 0.025 | 0.448 | 0.002 |
| WDR62 | 6.996 | 1092.750 | 38.060 | 31374.461 | 4.42E-05 |
| WDR72 | 1.220 | 3.387 | 1.251 | 9.169 | 0.016 |
Coef, coefficient; HR, hazard ratio; HR.95L, hazard ratio. 95% low; HR.95H, hazard ratio. 95% high.